Literature DB >> 19793899

Comparison of lateral flow technology and galactomannan and (1->3)-beta-D-glucan assays for detection of invasive pulmonary aspergillosis.

Nathan P Wiederhold1, Christopher R Thornton, Laura K Najvar, William R Kirkpatrick, Rosie Bocanegra, Thomas F Patterson.   

Abstract

We compared a lateral flow device to galactomannan and (1-->3)-beta-D-glucan assays to detect invasive aspergillosis in an established guinea pig model of pulmonary disease. The lateral flow device became positive earlier (day 3) than the (1-->3)-beta-D-glucan and galactomannan assays (day 5), with all samples positive by each assay on day 7.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19793899      PMCID： PMC2786380          DOI： 10.1128/CVI.00268-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  9 in total

1.  Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis.

Authors:  Viviane Balloy; Michel Huerre; Jean-Paul Latgé; Michel Chignard
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

2.  Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study.

Authors:  Johan Maertens; Koen Theunissen; Gregor Verhoef; Johnny Verschakelen; Katrien Lagrou; Eric Verbeken; Alexander Wilmer; Jan Verhaegen; Marc Boogaerts; Johan Van Eldere
Journal:  Clin Infect Dis       Date:  2005-09-29       Impact factor: 9.079

3.  Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay.

Authors:  Kieren A Marr; Michel Laverdiere; Anja Gugel; Wendy Leisenring
Journal:  Clin Infect Dis       Date:  2005-05-05       Impact factor: 9.079

4.  Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery.

Authors:  D Caillot; O Casasnovas; A Bernard; J F Couaillier; C Durand; B Cuisenier; E Solary; F Piard; T Petrella; A Bonnin; G Couillault; M Dumas; H Guy
Journal:  J Clin Oncol       Date:  1997-01       Impact factor: 44.544

5.  Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis.

Authors:  Christopher D Pfeiffer; Jason P Fine; Nasia Safdar
Journal:  Clin Infect Dis       Date:  2006-04-14       Impact factor: 9.079

6.  Assessment of Aspergillus fumigatus burden in pulmonary tissue of guinea pigs by quantitative PCR, galactomannan enzyme immunoassay, and quantitative culture.

Authors:  Ana C Vallor; William R Kirkpatrick; Laura K Najvar; Rosie Bocanegra; Marsha C Kinney; Annette W Fothergill; Monica L Herrera; Brian L Wickes; John R Graybill; Thomas F Patterson
Journal:  Antimicrob Agents Chemother       Date:  2008-05-12       Impact factor: 5.191

7.  Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome.

Authors:  Zekaver Odabasi; Gloria Mattiuzzi; Elihu Estey; Hagop Kantarjian; Fumihiro Saeki; Richard J Ridge; Paul A Ketchum; Malcolm A Finkelman; John H Rex; Luis Ostrosky-Zeichner
Journal:  Clin Infect Dis       Date:  2004-06-28       Impact factor: 9.079

8.  Development of an immunochromatographic lateral-flow device for rapid serodiagnosis of invasive aspergillosis.

Authors:  Christopher R Thornton
Journal:  Clin Vaccine Immunol       Date:  2008-05-07

9.  1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia.

Authors:  Laurence Senn; James Owen Robinson; Sabine Schmidt; Marlies Knaup; Nobuo Asahi; Shinji Satomura; Shuuji Matsuura; Bertrand Duvoisin; Jacques Bille; Thierry Calandra; Oscar Marchetti
Journal:  Clin Infect Dis       Date:  2008-03-15       Impact factor: 9.079
  9 in total
  15 in total

1.  Performance of Galactomannan Antigen, Beta-d-Glucan, and Aspergillus-Lateral-Flow Device for the Diagnosis of Invasive Aspergillosis.

Authors:  Gökhan Metan; Muzaffer Keklik; Gökçen Dinç; Çiğdem Pala; Afra Yıldırım; Berkay Saraymen; Mustafa Yavuz Köker; Leylagül Kaynar; Bülent Eser; Mustafa Çetin
Journal:  Indian J Hematol Blood Transfus       Date:  2016-02-09       Impact factor: 0.900

2.  Clinical utility and development of biomarkers in invasive aspergillosis.

Authors:  Thomas F Patterson
Journal:  Trans Am Clin Climatol Assoc       Date:  2011

3.  Evaluation of real-time PCR, galactomannan enzyme-linked immunosorbent assay (ELISA), and a novel lateral-flow device for diagnosis of invasive aspergillosis.

Authors:  P Lewis White; Christian Parr; Christopher Thornton; Rosemary A Barnes
Journal:  J Clin Microbiol       Date:  2013-03-13       Impact factor: 5.948

Review 4.  Molecular and nonmolecular diagnostic methods for invasive fungal infections.

Authors:  Marios Arvanitis; Theodora Anagnostou; Beth Burgwyn Fuchs; Angela M Caliendo; Eleftherios Mylonakis
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

5.  Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.

Authors:  M Hoenigl; J Prattes; B Spiess; J Wagner; F Prueller; R B Raggam; V Posch; W Duettmann; K Hoenigl; A Wölfler; C Koidl; W Buzina; M Reinwald; C R Thornton; R Krause; D Buchheidt
Journal:  J Clin Microbiol       Date:  2014-03-26       Impact factor: 5.948

6.  Submicronic fungal bioaerosols: high-resolution microscopic characterization and quantification.

Authors:  Komlavi Anani Afanou; Anne Straumfors; Asbjørn Skogstad; Terje Nilsen; Ole Synnes; Ida Skaar; Linda Hjeljord; Arne Tronsmo; Brett James Green; Wijnand Eduard
Journal:  Appl Environ Microbiol       Date:  2014-09-12       Impact factor: 4.792

Review 7.  Current challenges in the microbiological diagnosis of invasive aspergillosis.

Authors:  Jesús Guinea; Emilio Bouza
Journal:  Mycopathologia       Date:  2014-06-20       Impact factor: 2.574

8.  Comparison of a novel Aspergillus lateral-flow device and the Platelia® galactomannan assay for the diagnosis of invasive aspergillosis following haematopoietic stem cell transplantation.

Authors:  J Held; T Schmidt; C R Thornton; E Kotter; H Bertz
Journal:  Infection       Date:  2013-05-10       Impact factor: 3.553

9.  Interlaboratory and interstudy reproducibility of a novel lateral-flow device and influence of antifungal therapy on detection of invasive pulmonary aspergillosis.

Authors:  Nathan P Wiederhold; Laura K Najvar; Rosie Bocanegra; William R Kirkpatrick; Thomas F Patterson; Christopher R Thornton
Journal:  J Clin Microbiol       Date:  2012-11-21       Impact factor: 5.948

10.  Detection of invasive pulmonary aspergillosis in haematological malignancy patients by using lateral-flow technology.

Authors:  Christopher Thornton; Gemma Johnson; Samir Agrawal
Journal:  J Vis Exp       Date:  2012-03-22       Impact factor: 1.355
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.